PMC:7264098 / 20311-21055
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T306 | 0-22 | GO:1903561 | denotes | Extracellular vesicles |
| T307 | 586-596 | CL:0000034 | denotes | stem cells |
| T82799 | 0-22 | GO:1903561 | denotes | Extracellular vesicles |
| T77663 | 586-596 | CL:0000034 | denotes | stem cells |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 431 | 236-261 | Disease | denotes | damage by hostile disease | MESH:D004194 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T149 | 84-88 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T150 | 154-158 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T151 | 462-466 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T152 | 586-596 | Body_part | denotes | stem cells | http://purl.org/sig/ont/fma/fma63368 |
| T153 | 591-596 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T138 | 605-607 | Disease | denotes | EV | http://purl.obolibrary.org/obo/MONDO_0009176 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T216 | 84-88 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T217 | 154-158 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T218 | 462-466 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T219 | 586-596 | http://purl.obolibrary.org/obo/CL_0000034 | denotes | stem cells |
| T220 | 679-685 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T64 | 458-461 | Chemical | denotes | GMP | http://purl.obolibrary.org/obo/CHEBI_17345|http://purl.obolibrary.org/obo/CHEBI_58115 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T25 | 309-316 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | storage |
| T26 | 332-339 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | storage |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T120 | 0-103 | Sentence | denotes | Extracellular vesicles (EVs) are emerging as an attractive alternative to the whole cell–based therapy. |
| T121 | 104-317 | Sentence | denotes | EVs have several advantages compared to the whole cell therapy including lower risk of tumorigenic effects, lower susceptibility to damage by hostile disease microenvironment and possibility for long-term storage. |
| T122 | 318-500 | Sentence | denotes | The long-term storage is fundamental to make the treatment accessible in developing countries and it circumvents the need to have expensive GMP cell manufacturing facilities on-site. |
| T123 | 501-744 | Sentence | denotes | Nevertheless, production of EVs must follow the same strict guidelines that apply to stem cells and any EV-based therapy needs to be approved by the governing bodies after being tested in clinical trials to demonstrate the safety and efficacy. |